Literature DB >> 30151081

Synthesis and antitumoral activity of novel analogues monastrol-fatty acids against glioma cells.

Franciele S De Oliveira1, Patrick M De Oliveira2, Luana M Farias2, Rafael C Brinkerhoff2, Rui Carlos M A Sobrinho2, Tamara M Treptow2, Caroline R Montes D'Oca2, Marcelo A G Marinho1, Mariana A Hort3, Ana P Horn1, Dennis Russowsky4, Marcelo G Montes D'Oca2.   

Abstract

Monastrol is a small cell-permeable heterocyclic molecule that is recognized as an inhibitor of mitotic kinesin Eg5. Heterocyclic-fatty acid derivatives are a new class of compounds with a broad range of biological activities. This work describes a comparative study of the in vitro antitumoral activity of a series of new long-chain monastrol analogues against rat glioblastoma cells. The novel analogues C6-substituted monastrol and oxo-monastrol were synthesized via Biginelli multicomponent condensation of fatty β-ketoester in good yields using a simple approach catalyzed by nontoxic and free-metal sulfamic acid. Following synthesis, their in vitro antitumoral activities were investigated. Notably, all analogues tested were active against rat glioblastoma cells. Superior activity was observed by analogues derived from palmitic and stearic fatty acid chains; these compounds were the most potent molecules, showing 13-fold higher potency than monastrol with IC50 values of 5.11 and 6.85 μM, respectively. These compounds could provide promising new lead derivatives for more potent antitumor drugs.

Entities:  

Year:  2018        PMID: 30151081      PMCID: PMC6096354          DOI: 10.1039/c8md00169c

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  23 in total

Review 1.  Signal transduction therapy of cancer.

Authors:  Alexander Levitzki; Shoshana Klein
Journal:  Mol Aspects Med       Date:  2010-05-06

Review 2.  Lipophilicity and its relationship with passive drug permeation.

Authors:  Xiangli Liu; Bernard Testa; Alfred Fahr
Journal:  Pharm Res       Date:  2010-10-30       Impact factor: 4.200

3.  Monastrol inhibition of the mitotic kinesin Eg5.

Authors:  Jared C Cochran; Joseph E Gatial; Tarun M Kapoor; Susan P Gilbert
Journal:  J Biol Chem       Date:  2005-01-23       Impact factor: 5.157

Review 4.  An insight into the biological activities of heterocyclic-fatty acid hybrid molecules.

Authors:  Vijayendar Venepally; Ram Chandra Reddy Jala
Journal:  Eur J Med Chem       Date:  2017-10-03       Impact factor: 6.514

5.  Novel hybrid DHPM-fatty acids: synthesis and activity against glioma cell growth in vitro.

Authors:  Tamara G M Treptow; Fabrício Figueiró; Elisa H F Jandrey; Ana M O Battastini; Christianne G Salbego; Juliana B Hoppe; Priscila S Taborda; Sabrina B Rosa; Luciana A Piovesan; Caroline Da R Montes D'Oca; Dennis Russowsky; Marcelo G Montes D'Oca
Journal:  Eur J Med Chem       Date:  2015-03-28       Impact factor: 6.514

6.  Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents.

Authors:  G C Rovnyak; K S Atwal; A Hedberg; S D Kimball; S Moreland; J Z Gougoutas; B C O'Reilly; J Schwartz; M F Malley
Journal:  J Med Chem       Date:  1992-08-21       Impact factor: 7.446

Review 7.  Hybrid molecules with a dual mode of action: dream or reality?

Authors:  Bernard Meunier
Journal:  Acc Chem Res       Date:  2007-08-01       Impact factor: 22.384

8.  Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.

Authors:  K S Atwal; G C Rovnyak; J Schwartz; S Moreland; A Hedberg; J Z Gougoutas; M F Malley; D M Floyd
Journal:  J Med Chem       Date:  1990-05       Impact factor: 7.446

9.  Antitumor activity of a kinesin inhibitor.

Authors:  Roman Sakowicz; Jeffrey T Finer; Christophe Beraud; Anne Crompton; Evan Lewis; Alex Fritsch; Yan Lee; John Mak; Robert Moody; Rebecca Turincio; John C Chabala; Paul Gonzales; Stephanie Roth; Steve Weitman; Kenneth W Wood
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

10.  Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5.

Authors:  T M Kapoor; T U Mayer; M L Coughlin; T J Mitchison
Journal:  J Cell Biol       Date:  2000-09-04       Impact factor: 10.539

View more
  5 in total

1.  Nickel salt of phosphomolybdic acid as a bi-functional homogeneous recyclable catalyst for base free transformation of aldehyde into ester.

Authors:  Anjali Patel; Jay Patel
Journal:  RSC Adv       Date:  2020-06-09       Impact factor: 4.036

2.  Evaluation of the antioxidant activities of fatty polyhydroquinolines synthesized by Hantzsch multicomponent reactions.

Authors:  Rafael Centuriao Brinkerhoff; Eduarda Santa-Helena; Paulo C do Amaral; Diego da C Cabrera; Renata F Ongaratto; Patrick M de Oliveira; Caroline Da Ros Montes D'Oca; Carla A Neves Gonçalves; Luiz E Maia Nery; Marcelo G Montes D'Oca
Journal:  RSC Adv       Date:  2019-08-08       Impact factor: 4.036

3.  Tuning the Biginelli reaction mechanism by the ionic liquid effect: the combined role of supported heteropolyacid derivatives and acidic strength.

Authors:  Elon F Freitas; Roberto Y Souza; Saulo T A Passos; José A Dias; Silvia C L Dias; Brenno A D Neto
Journal:  RSC Adv       Date:  2019-08-29       Impact factor: 4.036

4.  A comparative study between Cu(INA)2-MOF and [Cu(INA)2(H2O)4] complex for a click reaction and the Biginelli reaction under solvent-free conditions.

Authors:  Julia C Mansano Willig; Gustavo Granetto; Danielly Reginato; Felipe R Dutra; Érica Fernanda Poruczinski; Isadora M de Oliveira; Helio A Stefani; Sílvia D de Campos; Élvio A de Campos; Flávia Manarin; Giancarlo V Botteselle
Journal:  RSC Adv       Date:  2020-01-21       Impact factor: 4.036

Review 5.  Mitotic Poisons in Research and Medicine.

Authors:  Jan Škubník; Michal Jurášek; Tomáš Ruml; Silvie Rimpelová
Journal:  Molecules       Date:  2020-10-12       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.